Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardized meal but not by forming marker ratios

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 12, 1996, Pages 1182-1188

  Oman H ^a   Henriksson, A E K ^a   Johansson, S G O ^a   Blomquist, L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biological markers; Ethylenediaminetetraacetic acid; Intestinal absorption; Macromolecular systems; Mannitol; Molecular weight; Non steroidal anti inflammatory drugs; Permeability; Polysucrose

Indexed keywords

BIOLOGICAL MARKER; EDETATE CHROMIUM CR 51; EDETIC ACID; MANNITOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; SUCROSE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; MEAL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0029828072     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609036908     Document Type: Article

References (24)

1. Fordtran JS, Rector FC, Ewton MF, Soter N. Kinney J. Permeability characteristics of the human small intestine. J Clin Invest 1965;44:1935-44.
2. Bjarnason I, Peters TJ, Levi AJ. Intestinal permeability: clinical correlates. Dig Dis 1986;4:83-92.
3. Travis S, Menzics I. Intestinal permeability: functional assessment and significance. Clin Sci 1992;82:471-88.
4. Menzies IS. Transmucosal passage of inert molecules in health and disease. In: Skadhauge E, Heintze K, editors. Falk symposium 36. Intestinal absorption and secretion. Lancaster: MTP Press Ltd, 1984:527-43.
5. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995;108:1566-81.
6. Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984;2:1171-4.
7. Oman H, Henriksson K, Blomquist L, Johansson SGO. Increased intestinal permeability to a synthetic polysucrose in NSAID-treated patients. Eur J Gastroenterol Hepatol 1992;4: 235-40.
8. Krugliak P, Hollander D, Le K, Ma T, Dadufalza VD, Katz KD. Regulation of polyethylene glycol 400 intestinal permeability by endogenous and exogenous prostanoids. Influence of non-steroidal anti-inflammatory drugs. Gut 1990;31:417-21.
9. Bjarnuson I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984;1: 179-82.
10. Öman H, Åkerblom E, Richter W, Johansson SGO. Chemical and physiological properties of polysucrose, a new marker of intestinal permeability to macromolecules. Int Arch Allergy Appl Immunol 1992;98:220-6.
11. Blomquist L., Öman H, Henriksson K, Johansson SGO. Increased absorption of polysucrose, a marker of intestinal paracellulur permeability, in Crohn's disease. Fur J Gastroenterol Hepatol 1993;5:913-7.
12. 14C-mannitol as markers of intestinal permeability in man. Scand J Gastroenterol 1995;30:1172-7.
13. Laker MF, Menzies IS. Increase in human intestinal permeability following ingestion of hypertonic solutions. J Physiol (Lond) 1977;265:881-94.
14. Bjarnason I, Maxton D, Reynolds AP, Call S, Peters TJ, Menzies IS. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease. Scand J Gastroenterol 1994;29:630-9.
15. Peeters M, Hiele M, Ghoos Y, Huysmans V, Geboes K, Vantrappen G, et al. Test conditions greatly influence permeation of water soluble molecules through the intestinal mucosa: need for standardisation. Gut 1994;35:1404-8.
16. Juby LD, Rothwell J, Axon AT. Lactulose/mannitol test: an ideal screen for celiac disease. Gastroenterology 1989;96:79-85.
17. Behrens RH, Szaz KF, Northrop C,. Elia M, Neale G. Radio-nuclide tests for the assessment of intestinal permeability. Eur J Clin Invest 1987;17:100-5.
18. 14 C-mannitol methods for intestinal permeability. Frequency distribution pattern and variability of marker ratios in healthy subjects. Scand J Gastroenterol 1993; 28:274-80.
19. Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987;93: 480-9.
20. Laker MF, Bull HJ, Menzies IS. Evaluation of mannitol for use as a probe marker of gastrointestinal permeability in man. Eur J Clin Invest 1982;12:485-91.
21. 2 breath test as a measure of mouth to caecum transit time. Gut 1983;24:893-6.
22. Korth H, Müller I, Erckenbrecht JF, Wienbeck M. Breath hydrogen as a test for gastrointestinal transit. Hepatogastroenterology 1984;31:282-4.
23. Jenkins AP, Menzies IS, Nukajam WS, Creamer B. The effect of ingested lactulose on absorption of L-rhamnose, D-xylose, and 3-O-methyl-D-glucose in subjects with ileostomies. Scand J Gastroenterol 1994;29:820-5.
24. 51Cr-labelled ethylene-diaminetetraacetic acid in healthy subjects. Scand J Gastroenterol 1996;31:254-9.